SlideShare a Scribd company logo
1 of 50
Narcotics, Narcotic Antagonists, 
and Antimigraine Agents 
Chapter 26 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pain 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Definition 
– Sensory and emotional experience associated with 
actual or potential tissue damage 
• Drugs Used to Relieve Pain 
– Narcotics: Opium derivatives used to treat many 
types of pain 
– Antimigraine Drugs: Reserved for the treatment of 
migraine headaches
Neural Pathways of Pain 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Gate-Control Theory of Pain 
• Sensory and emotional experience 
• Transmission of these impulses can be modulated or 
adjusted 
• Interneurons can act as “gates” 
• Several factors, including learned experiences, cultural 
expectations, individual tolerance, and the placebo effect, 
can activate the descending inhibitory nerves from the 
upper central nervous system 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Location of Opioid Receptors 
• CNS 
• Nerves in the periphery 
• Cells in the gastrointestinal (GI) tract 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Agonists 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Act at specific opioid receptor sites in the CNS 
– Produce analgesia, sedation, and a sense of well-being 
• Indications 
– Relief of severe acute or chronic pain 
– Analgesia during anesthesia 
– Cross placenta
Narcotic Agonists (cont.) 
• Pharmacokinetics 
– IV most reliable way to achieve therapeutic response 
– IM and sub-q rate of absorption varies 
– Hepatic metabolism and generally excreted in the 
urine and bile 
• Contraindications 
– Known allergy 
– Pregnancy, labor, lactation 
– Diarrhea caused by poisons 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Agonists (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Cautions 
– Respiratory dysfunction 
– GI or GU surgery 
– Acute abdomen or ulcerative colitis 
• Adverse Reactions 
– Respiratory depression with apnea 
– Cardiac arrest
Narcotic Agonists (cont.) 
• Adverse Reactions (cont.) 
– Shock 
– Orthostatic hypotension 
– Nausea, vomiting, constipation 
– Biliary spasm 
– Dizziness, psychoses, anxiety, fear, hallucinations 
• Drug-to-Drug Interactions 
– Barbiturate general anesthetics, phenothiazines, and 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
MAOIs
Question 
Identify a reason a narcotic agonist may be prescribed? 
A. Relief of minor pain 
B. Analgesia during anesthesia 
C. Analgesia during sleep 
D. Relief of moderate acute pain 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
b. Analgesia during anesthesia 
Rationale: Indications: 
– Relief of severe acute or chronic pain 
– Analgesia during anesthesia 
– Cross placenta 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Agonists–Antagonists 
• Buprenorphine (Buprenex) 
– Treats mild to moderate pain 
• Butorphanol (Stadol, Stadol NS) 
– Preoperative medication 
– Relieves moderate to severe pain 
• Nalbuphine (Nubain) 
– Treats moderate to severe pain 
– Adjunct for general anesthesia 
– Relieves pain during labor and delivery 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Agonists–Antagonists (cont.) 
• Pentazocine (Talwin) 
– Preferred drug for patients switched from parenteral 
to oral forms after surgery or labor 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Agonists–Antagonists (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Act at a specific opioid receptor sites in the CNS to 
produce analgesia, sedation, euphoria, and 
hallucinations 
• Indications 
– Moderate to severe pain 
– Adjunct to general anesthesia 
– Relief of pain during labor and delivery
Narcotic Agonists–Antagonists (cont.) 
• Pharmacokinetics 
– Readily absorbed IM and reach peak levels when 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
given IV 
– Metabolized in the liver excreted in urine or feces 
– Cross placenta 
• Contraindications 
– Known allergy 
– Pregnancy and lactation
Narcotic Agonists–Antagonists (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Cautions 
– Physical dependence on a narcotic 
– COPD and disease of the respiratory tract 
– Acute MI or documented CAD 
• Adverse Reactions 
– Respiratory depression 
– Nausea, vomiting, constipation, and biliary spasm
Narcotic Agonists–Antagonists (cont.) 
• Adverse Reactions 
– Headache 
– Dizziness 
– Psychoses 
– Anxiety 
– Hallucinations 
– Ureteral spasm, urinary retention 
• Drug-to-Drug Interactions 
– Barbiturate general anesthetics 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Antagonists 
• Nalmefene (Revex) 
– Reverses the effects of narcotics; manages known or 
suspected narcotic overdose 
• Naloxone (Narcan) 
– Reverses adverse effects of narcotics; diagnoses 
suspected acute narcotic overdose 
• Naltrexone (ReVia) 
– Used orally in the management of alcohol or narcotic 
dependence 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Antagonists (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Drugs that bind strongly to opioid receptors, but they 
do not activate the receptors 
– Reverse effects of opioids 
• Indications 
– Reversal of the adverse effects of narcotics 
– Treat narcotic and/or alcoholic dependence
Narcotic Antagonists (cont.) 
• Pharmacokinetics 
– Well absorbed after injection and are widely 
distributed in the body 
– Hepatic metabolism and excreted in the urine 
– Enter breast milk 
• Contraindications 
– Known allergy 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Antagonists (cont.) 
• Adverse Reactions 
– Tachycardia 
– Blood pressure changes 
– Dysrhythmias 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Narcotic Antagonists (cont.) 
• Drug-to-Drug Interactions 
– Reverse Effects on: 
• Buprenorphine 
• Butorphanol 
• Nalbuphine 
• Pentazocine 
• Propoxyphene 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
Identify one indicator for a narcotic antagonist to be 
prescribed? 
A. Treatment of alcohol independence 
B. Reversal of bronchoconstriction 
C. Treatment of narcotic dependence 
D. Reversal of tachycardia 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
C. Treatment of narcotic dependence 
Rationale: Indications 
– Reversal of the adverse effects of narcotics 
– Treat narcotic and/or alcoholic dependence 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Headaches 
• Migraine Headaches 
– Severe, throbbing headaches on one side of the head 
• Cluster Headaches 
– Begin during sleep; involve sharp, steady eye pain, 
sweating, flushing, tearing, and nasal congestion 
• Tension Headaches 
– Usually occur at times of stress; dull band of pain 
around the entire head 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Ergot Derivatives 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Block alpha-adrenergic and serotonin receptor sites 
in the brain to cause constriction of cranial vessels 
• Indications 
– Prevention or abortion or migraine or vascular 
headaches
Ergot Derivatives (cont.) 
• Pharmacokinetics 
– Rapidly absorbed from many routes 
– Onset of action range from 15-30 minutes 
– Metabolized in the liver and primarily excreted in the 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
bile 
– Excreted in breast milk
Ergot Derivatives (cont.) 
• Contraindications 
– Known allergy 
– Pregnancy or lactation 
– CAD 
– HTN 
– PVD 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Cautions 
– Pruitus 
– Malnutrition
Ergot Derivatives (cont.) 
• Adverse Reactions 
– Numbness 
– Tingling of extremities 
– Muscle pain 
– Pulselessness 
– Weakness 
– Chest pain 
– Arrhythmias 
– Nausea 
– Vomiting 
– Diarrhea 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Ergot Derivatives (cont.) 
• Drug-to-Drug Interactions 
– Beta blockers 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Triptans 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Actions 
– Bind to selective serotonin receptors sites to cause 
vasoconstriction of cranial vessels 
• Indications 
– Treatment of acute migraine and are not used for 
prevention of migraines
Triptans (cont.) 
• Pharmacokinetics 
– Rapidly absorbed from many sites 
– Metabolized in the liver 
– Primarily excreted in the urine 
– Cross the placenta and enter breast milk 
• Contraindications 
– Known allergy, pregnancy, CAD 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Triptans (cont.) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
• Cautions 
– Elderly, risk factors for CAD, and lactation 
• Adverse Reactions 
– Numbness, tingling, burning sensation, feeling of 
coldness, weakness, dysphasia, blood pressure 
alterations 
• Drug-to-Drug Interactions 
– Ergot – containing drugs 
– MAOI’s
Use of Narcotics and Antimigraine Agents Across 
the Lifespan 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Narcotic Agonists 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Narcotic Agonists–Antagonists 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Narcotic Antagonists 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Narcotic Antagonists 
(Continued) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Ergot Derivatives 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Ergot Derivatives (Continued) 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Triptans 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
What is an action of Ergotamine? 
A. Decreases hyperfusion of basilar artery vascular bed 
B. Increases hyperfusion of basilar artery vascular bed 
C. Increases hypoperfusion of basilar artery vascular bed 
D. Decreases hypoperfusion of basilar artery vascular bed 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
A. Decreases hyperfusion of basilar artery vascular bed 
Rationale: Actions: Constricts cranial blood vessels, 
decreases pulsation of cranial arteries, and decreases 
hyperfusion of basilar artery vascular bed; mechanism of 
action is not understood 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Narcotic Agonists 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Narcotic Agonists– 
Antagonists 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Narcotic Antagonists 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Ergot Derivatives 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Triptans 
• Assessment: History and Physical Exam 
• Nursing Diagnosis 
• Implementation 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
The nurse is caring for a patient with Parkinson’s disease. 
While writing the care plan for this patient what would be 
an appropriate nursing diagnosis? 
A. Constipation related to dopaminergic effects 
B. Diarrhea related to dopaminergic effects 
C. Risk for injury related to CVS effects and incidence of 
orthostatic hypotension 
D. Risk for injury related to CVS effects and incidence of 
PVD 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
A. Constipation related to dopaminergic effects 
Rationale: Nursing diagnoses related to drug therapy might 
include: Constipation related to dopaminergic effects; 
Risk for injury related to CNS effects and incidence of 
orthostatic hypertension 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

More Related Content

What's hot

Ppt chapter 30-1
Ppt chapter 30-1Ppt chapter 30-1
Ppt chapter 30-1stanbridge
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18stanbridge
 
Ppt chapter 20-1
Ppt chapter 20-1Ppt chapter 20-1
Ppt chapter 20-1stanbridge
 
Ppt chapter 26
Ppt chapter 26Ppt chapter 26
Ppt chapter 26stanbridge
 
Ppt chapter 31
Ppt chapter 31Ppt chapter 31
Ppt chapter 31stanbridge
 
Ppt chapter 29
Ppt chapter 29Ppt chapter 29
Ppt chapter 29stanbridge
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41stanbridge
 
Antibiotics(Cephalosporins • FluoroquinolonesTetracyclines)
Antibiotics(Cephalosporins • FluoroquinolonesTetracyclines)Antibiotics(Cephalosporins • FluoroquinolonesTetracyclines)
Antibiotics(Cephalosporins • FluoroquinolonesTetracyclines)Md.Mustahasin Karim
 
NurseReview.Org - Pharmacology Git Drugs
NurseReview.Org - Pharmacology Git DrugsNurseReview.Org - Pharmacology Git Drugs
NurseReview.Org - Pharmacology Git DrugsNurse ReviewDotOrg
 
Ppt chapter 04
Ppt chapter 04Ppt chapter 04
Ppt chapter 04stanbridge
 
Levoflox (Levofloxacin Tablets)
Levoflox (Levofloxacin Tablets)Levoflox (Levofloxacin Tablets)
Levoflox (Levofloxacin Tablets)Clearsky Pharmacy
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16stanbridge
 
Endrocrine drugs
Endrocrine drugsEndrocrine drugs
Endrocrine drugsUmair hanif
 
Pharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugsPharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugsSaleem Cology
 
Respiratory drugs
Respiratory drugsRespiratory drugs
Respiratory drugsaminqorbani
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36stanbridge
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepilepticsmayur kale
 
SKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTSSKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTSDr.Arka Mondal
 
Ppt chapter 13
Ppt chapter 13Ppt chapter 13
Ppt chapter 13stanbridge
 

What's hot (20)

Ppt chapter 30-1
Ppt chapter 30-1Ppt chapter 30-1
Ppt chapter 30-1
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18
 
Ppt chapter 20-1
Ppt chapter 20-1Ppt chapter 20-1
Ppt chapter 20-1
 
Ppt chapter 26
Ppt chapter 26Ppt chapter 26
Ppt chapter 26
 
Ppt chapter 31
Ppt chapter 31Ppt chapter 31
Ppt chapter 31
 
Ppt chapter 29
Ppt chapter 29Ppt chapter 29
Ppt chapter 29
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
 
Antibiotics(Cephalosporins • FluoroquinolonesTetracyclines)
Antibiotics(Cephalosporins • FluoroquinolonesTetracyclines)Antibiotics(Cephalosporins • FluoroquinolonesTetracyclines)
Antibiotics(Cephalosporins • FluoroquinolonesTetracyclines)
 
NurseReview.Org - Pharmacology Git Drugs
NurseReview.Org - Pharmacology Git DrugsNurseReview.Org - Pharmacology Git Drugs
NurseReview.Org - Pharmacology Git Drugs
 
Ppt chapter 04
Ppt chapter 04Ppt chapter 04
Ppt chapter 04
 
Levoflox (Levofloxacin Tablets)
Levoflox (Levofloxacin Tablets)Levoflox (Levofloxacin Tablets)
Levoflox (Levofloxacin Tablets)
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
 
Endrocrine drugs
Endrocrine drugsEndrocrine drugs
Endrocrine drugs
 
Pharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugsPharmacology of antidiabetic drugs
Pharmacology of antidiabetic drugs
 
Respiratory drugs
Respiratory drugsRespiratory drugs
Respiratory drugs
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Antidiabetic agent
Antidiabetic agent Antidiabetic agent
Antidiabetic agent
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
SKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTSSKELETAL MUSCLE RELAXANTS
SKELETAL MUSCLE RELAXANTS
 
Ppt chapter 13
Ppt chapter 13Ppt chapter 13
Ppt chapter 13
 

Viewers also liked

Ppt chapter 32
Ppt chapter 32Ppt chapter 32
Ppt chapter 32stanbridge
 
Ppt chapter 21
Ppt chapter 21Ppt chapter 21
Ppt chapter 21stanbridge
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40stanbridge
 
Congenital disorders of female reproductive tract
Congenital disorders of female reproductive tractCongenital disorders of female reproductive tract
Congenital disorders of female reproductive tract762060
 
Ppt chapter 29-1
Ppt chapter 29-1Ppt chapter 29-1
Ppt chapter 29-1stanbridge
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52stanbridge
 
Aids approach patients
Aids approach patientsAids approach patients
Aids approach patientsMohd Hanafi
 
Ppt chapter 21
Ppt chapter 21Ppt chapter 21
Ppt chapter 21stanbridge
 
Ppt chapter 22
Ppt chapter 22Ppt chapter 22
Ppt chapter 22stanbridge
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40stanbridge
 
Ppt on assessmaent of female reproductive system
Ppt on assessmaent of female reproductive systemPpt on assessmaent of female reproductive system
Ppt on assessmaent of female reproductive systemshimi123456
 
Week 5 Powerpoint Chapter 45
Week 5 Powerpoint Chapter 45Week 5 Powerpoint Chapter 45
Week 5 Powerpoint Chapter 45stanbridge
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20stanbridge
 
Ppt chapter 25
Ppt chapter 25Ppt chapter 25
Ppt chapter 25stanbridge
 
Ppt chapter 28
Ppt chapter 28Ppt chapter 28
Ppt chapter 28stanbridge
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35stanbridge
 

Viewers also liked (19)

Ppt chapter 32
Ppt chapter 32Ppt chapter 32
Ppt chapter 32
 
Ppt chapter 21
Ppt chapter 21Ppt chapter 21
Ppt chapter 21
 
Chapter 40.ppt
Chapter 40.pptChapter 40.ppt
Chapter 40.ppt
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40
 
Congenital disorders of female reproductive tract
Congenital disorders of female reproductive tractCongenital disorders of female reproductive tract
Congenital disorders of female reproductive tract
 
Chapter 35 HIV Presentation
Chapter 35 HIV PresentationChapter 35 HIV Presentation
Chapter 35 HIV Presentation
 
Ppt chapter 29-1
Ppt chapter 29-1Ppt chapter 29-1
Ppt chapter 29-1
 
Chapter040
Chapter040Chapter040
Chapter040
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52
 
Aids approach patients
Aids approach patientsAids approach patients
Aids approach patients
 
Ppt chapter 21
Ppt chapter 21Ppt chapter 21
Ppt chapter 21
 
Ppt chapter 22
Ppt chapter 22Ppt chapter 22
Ppt chapter 22
 
Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40
 
Ppt on assessmaent of female reproductive system
Ppt on assessmaent of female reproductive systemPpt on assessmaent of female reproductive system
Ppt on assessmaent of female reproductive system
 
Week 5 Powerpoint Chapter 45
Week 5 Powerpoint Chapter 45Week 5 Powerpoint Chapter 45
Week 5 Powerpoint Chapter 45
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20
 
Ppt chapter 25
Ppt chapter 25Ppt chapter 25
Ppt chapter 25
 
Ppt chapter 28
Ppt chapter 28Ppt chapter 28
Ppt chapter 28
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35
 

Similar to Ppt chapter 26-1

Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59stanbridge
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59stanbridge
 
Ppt chapter 16-1
Ppt chapter 16-1Ppt chapter 16-1
Ppt chapter 16-1stanbridge
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52stanbridge
 
Ppt chapter 52-1
Ppt chapter 52-1Ppt chapter 52-1
Ppt chapter 52-1stanbridge
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20stanbridge
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36stanbridge
 
Ppt chapter 46
Ppt chapter 46Ppt chapter 46
Ppt chapter 46stanbridge
 
Ppt chapter 31-1
Ppt chapter 31-1Ppt chapter 31-1
Ppt chapter 31-1stanbridge
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48stanbridge
 
Ppt chapter 57
Ppt chapter 57Ppt chapter 57
Ppt chapter 57stanbridge
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58stanbridge
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58stanbridge
 
Ppt chapter 24-1
Ppt chapter 24-1Ppt chapter 24-1
Ppt chapter 24-1stanbridge
 
Ppt chapter 24
Ppt chapter 24Ppt chapter 24
Ppt chapter 24stanbridge
 
Ppt chapter 15
Ppt chapter 15Ppt chapter 15
Ppt chapter 15stanbridge
 

Similar to Ppt chapter 26-1 (20)

Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 16-1
Ppt chapter 16-1Ppt chapter 16-1
Ppt chapter 16-1
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52
 
Ppt chapter 52-1
Ppt chapter 52-1Ppt chapter 52-1
Ppt chapter 52-1
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Ppt chapter 46
Ppt chapter 46Ppt chapter 46
Ppt chapter 46
 
Ppt chapter 31-1
Ppt chapter 31-1Ppt chapter 31-1
Ppt chapter 31-1
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48
 
Ppt chapter 57
Ppt chapter 57Ppt chapter 57
Ppt chapter 57
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
 
Ppt chapter 58
Ppt chapter 58Ppt chapter 58
Ppt chapter 58
 
Ppt chapter 24-1
Ppt chapter 24-1Ppt chapter 24-1
Ppt chapter 24-1
 
Ppt chapter 24
Ppt chapter 24Ppt chapter 24
Ppt chapter 24
 
Ppt chapter 15
Ppt chapter 15Ppt chapter 15
Ppt chapter 15
 

More from stanbridge

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecturestanbridge
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2stanbridge
 
Creating a poster
Creating a posterCreating a poster
Creating a posterstanbridge
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Disseminationstanbridge
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5stanbridge
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4stanbridge
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors stanbridge
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learnerstanbridge
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policystanbridge
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentstanbridge
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005stanbridge
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007stanbridge
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006stanbridge
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004stanbridge
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009stanbridge
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008stanbridge
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21stanbridge
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22stanbridge
 

More from stanbridge (20)

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecture
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2
 
Creating a poster
Creating a posterCreating a poster
Creating a poster
 
Sample poster
Sample posterSample poster
Sample poster
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Dissemination
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learner
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policy
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessment
 
Ot5101 week1
Ot5101 week1Ot5101 week1
Ot5101 week1
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22
 

Ppt chapter 26-1

  • 1. Narcotics, Narcotic Antagonists, and Antimigraine Agents Chapter 26 Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 2. Pain Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Definition – Sensory and emotional experience associated with actual or potential tissue damage • Drugs Used to Relieve Pain – Narcotics: Opium derivatives used to treat many types of pain – Antimigraine Drugs: Reserved for the treatment of migraine headaches
  • 3. Neural Pathways of Pain Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 4. Gate-Control Theory of Pain • Sensory and emotional experience • Transmission of these impulses can be modulated or adjusted • Interneurons can act as “gates” • Several factors, including learned experiences, cultural expectations, individual tolerance, and the placebo effect, can activate the descending inhibitory nerves from the upper central nervous system Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 5. Location of Opioid Receptors • CNS • Nerves in the periphery • Cells in the gastrointestinal (GI) tract Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 6. Narcotic Agonists Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Act at specific opioid receptor sites in the CNS – Produce analgesia, sedation, and a sense of well-being • Indications – Relief of severe acute or chronic pain – Analgesia during anesthesia – Cross placenta
  • 7. Narcotic Agonists (cont.) • Pharmacokinetics – IV most reliable way to achieve therapeutic response – IM and sub-q rate of absorption varies – Hepatic metabolism and generally excreted in the urine and bile • Contraindications – Known allergy – Pregnancy, labor, lactation – Diarrhea caused by poisons Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 8. Narcotic Agonists (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Cautions – Respiratory dysfunction – GI or GU surgery – Acute abdomen or ulcerative colitis • Adverse Reactions – Respiratory depression with apnea – Cardiac arrest
  • 9. Narcotic Agonists (cont.) • Adverse Reactions (cont.) – Shock – Orthostatic hypotension – Nausea, vomiting, constipation – Biliary spasm – Dizziness, psychoses, anxiety, fear, hallucinations • Drug-to-Drug Interactions – Barbiturate general anesthetics, phenothiazines, and Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins MAOIs
  • 10. Question Identify a reason a narcotic agonist may be prescribed? A. Relief of minor pain B. Analgesia during anesthesia C. Analgesia during sleep D. Relief of moderate acute pain Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 11. Answer b. Analgesia during anesthesia Rationale: Indications: – Relief of severe acute or chronic pain – Analgesia during anesthesia – Cross placenta Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 12. Narcotic Agonists–Antagonists • Buprenorphine (Buprenex) – Treats mild to moderate pain • Butorphanol (Stadol, Stadol NS) – Preoperative medication – Relieves moderate to severe pain • Nalbuphine (Nubain) – Treats moderate to severe pain – Adjunct for general anesthesia – Relieves pain during labor and delivery Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 13. Narcotic Agonists–Antagonists (cont.) • Pentazocine (Talwin) – Preferred drug for patients switched from parenteral to oral forms after surgery or labor Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 14. Narcotic Agonists–Antagonists (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Act at a specific opioid receptor sites in the CNS to produce analgesia, sedation, euphoria, and hallucinations • Indications – Moderate to severe pain – Adjunct to general anesthesia – Relief of pain during labor and delivery
  • 15. Narcotic Agonists–Antagonists (cont.) • Pharmacokinetics – Readily absorbed IM and reach peak levels when Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins given IV – Metabolized in the liver excreted in urine or feces – Cross placenta • Contraindications – Known allergy – Pregnancy and lactation
  • 16. Narcotic Agonists–Antagonists (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Cautions – Physical dependence on a narcotic – COPD and disease of the respiratory tract – Acute MI or documented CAD • Adverse Reactions – Respiratory depression – Nausea, vomiting, constipation, and biliary spasm
  • 17. Narcotic Agonists–Antagonists (cont.) • Adverse Reactions – Headache – Dizziness – Psychoses – Anxiety – Hallucinations – Ureteral spasm, urinary retention • Drug-to-Drug Interactions – Barbiturate general anesthetics Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 18. Narcotic Antagonists • Nalmefene (Revex) – Reverses the effects of narcotics; manages known or suspected narcotic overdose • Naloxone (Narcan) – Reverses adverse effects of narcotics; diagnoses suspected acute narcotic overdose • Naltrexone (ReVia) – Used orally in the management of alcohol or narcotic dependence Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 19. Narcotic Antagonists (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Drugs that bind strongly to opioid receptors, but they do not activate the receptors – Reverse effects of opioids • Indications – Reversal of the adverse effects of narcotics – Treat narcotic and/or alcoholic dependence
  • 20. Narcotic Antagonists (cont.) • Pharmacokinetics – Well absorbed after injection and are widely distributed in the body – Hepatic metabolism and excreted in the urine – Enter breast milk • Contraindications – Known allergy Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 21. Narcotic Antagonists (cont.) • Adverse Reactions – Tachycardia – Blood pressure changes – Dysrhythmias Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 22. Narcotic Antagonists (cont.) • Drug-to-Drug Interactions – Reverse Effects on: • Buprenorphine • Butorphanol • Nalbuphine • Pentazocine • Propoxyphene Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 23. Question Identify one indicator for a narcotic antagonist to be prescribed? A. Treatment of alcohol independence B. Reversal of bronchoconstriction C. Treatment of narcotic dependence D. Reversal of tachycardia Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 24. Answer C. Treatment of narcotic dependence Rationale: Indications – Reversal of the adverse effects of narcotics – Treat narcotic and/or alcoholic dependence Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 25. Headaches • Migraine Headaches – Severe, throbbing headaches on one side of the head • Cluster Headaches – Begin during sleep; involve sharp, steady eye pain, sweating, flushing, tearing, and nasal congestion • Tension Headaches – Usually occur at times of stress; dull band of pain around the entire head Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 26. Ergot Derivatives Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Block alpha-adrenergic and serotonin receptor sites in the brain to cause constriction of cranial vessels • Indications – Prevention or abortion or migraine or vascular headaches
  • 27. Ergot Derivatives (cont.) • Pharmacokinetics – Rapidly absorbed from many routes – Onset of action range from 15-30 minutes – Metabolized in the liver and primarily excreted in the Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins bile – Excreted in breast milk
  • 28. Ergot Derivatives (cont.) • Contraindications – Known allergy – Pregnancy or lactation – CAD – HTN – PVD Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Cautions – Pruitus – Malnutrition
  • 29. Ergot Derivatives (cont.) • Adverse Reactions – Numbness – Tingling of extremities – Muscle pain – Pulselessness – Weakness – Chest pain – Arrhythmias – Nausea – Vomiting – Diarrhea Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 30. Ergot Derivatives (cont.) • Drug-to-Drug Interactions – Beta blockers Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 31. Triptans Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Actions – Bind to selective serotonin receptors sites to cause vasoconstriction of cranial vessels • Indications – Treatment of acute migraine and are not used for prevention of migraines
  • 32. Triptans (cont.) • Pharmacokinetics – Rapidly absorbed from many sites – Metabolized in the liver – Primarily excreted in the urine – Cross the placenta and enter breast milk • Contraindications – Known allergy, pregnancy, CAD Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 33. Triptans (cont.) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins • Cautions – Elderly, risk factors for CAD, and lactation • Adverse Reactions – Numbness, tingling, burning sensation, feeling of coldness, weakness, dysphasia, blood pressure alterations • Drug-to-Drug Interactions – Ergot – containing drugs – MAOI’s
  • 34. Use of Narcotics and Antimigraine Agents Across the Lifespan Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 35. Prototype Narcotic Agonists Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 36. Prototype Narcotic Agonists–Antagonists Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 37. Prototype Narcotic Antagonists Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 38. Prototype Narcotic Antagonists (Continued) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 39. Prototype Ergot Derivatives Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 40. Prototype Ergot Derivatives (Continued) Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 41. Prototype Triptans Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 42. Question What is an action of Ergotamine? A. Decreases hyperfusion of basilar artery vascular bed B. Increases hyperfusion of basilar artery vascular bed C. Increases hypoperfusion of basilar artery vascular bed D. Decreases hypoperfusion of basilar artery vascular bed Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 43. Answer A. Decreases hyperfusion of basilar artery vascular bed Rationale: Actions: Constricts cranial blood vessels, decreases pulsation of cranial arteries, and decreases hyperfusion of basilar artery vascular bed; mechanism of action is not understood Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 44. Nursing Considerations for Narcotic Agonists • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 45. Nursing Considerations for Narcotic Agonists– Antagonists • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 46. Nursing Considerations for Narcotic Antagonists • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 47. Nursing Considerations for Ergot Derivatives • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 48. Nursing Considerations for Triptans • Assessment: History and Physical Exam • Nursing Diagnosis • Implementation • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 49. Question The nurse is caring for a patient with Parkinson’s disease. While writing the care plan for this patient what would be an appropriate nursing diagnosis? A. Constipation related to dopaminergic effects B. Diarrhea related to dopaminergic effects C. Risk for injury related to CVS effects and incidence of orthostatic hypotension D. Risk for injury related to CVS effects and incidence of PVD Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 50. Answer A. Constipation related to dopaminergic effects Rationale: Nursing diagnoses related to drug therapy might include: Constipation related to dopaminergic effects; Risk for injury related to CNS effects and incidence of orthostatic hypertension Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins